News Articles and Montana BioScience Alliance Newsletters
Manually converting FASTQs to VCFs, importing these into VarSeq, and building projects from scratch is adequate when you have only a handful of cases per week. But as you start ramping up production, the key to your lab’s success quickly becomes how quickly and efficiently you can get to the reporting of your analysis. This blog will explain how you can automate the VCF and VarSeq Project generation process that requires only a few commands. This will expedite your path to analysis […]
Tonix Pharmaceuticals has received a grant from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to support development of TNX-1300 a recombinant enzyme that efficiently degrades and metabolizes cocaine. In 2021, more than 24,900 individuals in the U.S. died from drug overdose deaths involving cocaine.
Endosymbionts are little critters that actually live inside the cells of other organisms. A University of Montana researcher recently earned a $1.5 million grant from the National Science Foundation to study these organisms – especially how they interact with their hosts and the environment – which could help improve health for a huge swath of the world’s population.
When future astronauts heading to Mars sit down to a hearty supper in their spaceship, they may dine on a nutritious, meat-like product made from a microbe that Montana State University scientists discovered in a Yellowstone National Park hot spring.
The four-year grant will enable MSU and its partners from across Montana to deliver quality medical, dental and behavioral health care to kids in rural and underserved areas while providing exceptional educational opportunities for MSU students.
As a new year begins in Congress, the Biotechnology Innovation Organization (BIO) is carrying over many of its legislative priorities from last year.
Administrative Supplements to Promote Diversity in Research and Development Small Businesses – SBIR/STTR
Contract Pre-solicitation for R&D that will contribute toward ARPA-H mission needs and SBIR program objectives.
Updates from product development and small business programs
The wait is finally over as the Biotechnology Innovation Organization (BIO) taps John F. Crowley, a longtime leader and tireless patient advocate in the biotech industry, to fill the role of the organization’s new CEO.